Women may struggle to get diagnoses for health problems, including sleep apnea and heart conditions, early enough if their symptoms are misattributed to anxiety.
The FDA granted full approval to the menin inhibitor revumenib (Revuforj) for adults and children 1 year and older with relapsed/refractory acute leukemia and a lysine methyltransferase 2A gene ( ...